Physician profile
Robert N Winter
NPI 1174633135
$496.50
in general payments reported to CMS, 2019-2025
13 companies · $91.37 in 2025
The $91.37 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $11.74 · 2022: $31.07 · 2023: $224 · 2024: $24.13 · 2025: $91.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $109.80 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Merck Sharp & Dohme LLC | $68.76 | 2019-2024 | Gardasil 9, Gardasil |
| Aspira Women'S Health INC | $64.24 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $52.69 | 2022-2023 | Aptima |
| Organon LLC | $35.33 | 2023-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $28.21 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $28.12 | 2025 | |
| Minerva Surgical, INC | $24.71 | 2019-2023 | |
| Daiichi Sankyo INC. | $22.05 | 2025 | Injectafer |
| Coopersurgical, INC. | $20.61 | 2023 | Paragard T 380a |
| Ethicon US, LLC | $15.79 | 2025 | Evarrest, Ethicon, Stratafix |
| Meditrina | $14.45 | 2025 | |
| Kci USA, INC. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.